| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Revenue: | ||||||
Total revenue | ||||||
280,067 | 406,133 | 373,732 | 259,565 | 273,300 | 278,807 | |
Operating expenses: | ||||||
Cost of revenue | ||||||
8,460 | 13,291 | 6,308 | 551 | 566 | 384 | |
Research, development and other related costs | ||||||
112,345 | 106,406 | 105,849 | 44,738 | 32,181 | 32,270 | |
Selling, general and administrative | ||||||
122,897 | 127,907 | 144,649 | 72,065 | 43,592 | 47,208 | |
Amortization expense | ||||||
99,900 | 108,500 | 111,900 | 31,870 | 20,624 | 18,471 | |
Litigation expense | ||||||
5,127 | 26,099 | 36,496 | 20,953 | 14,135 | 25,116 | |
Gain on the sale of patents and restructuring | ||||||
- | - | - | - | - | -10,338 | |
Total operating expenses | ||||||
348,775 | 382,153 | 405,232 | 170,177 | 111,098 | 113,111 | |
Operating income (loss) | ||||||
-68,708 | 23,980 | -31,500 | 89,388 | 162,202 | 165,696 | |
Interest expense | ||||||
23,377 | 25,665 | 28,292 | 2,409 | 0 | 0 | |
Other income and expense, net | ||||||
9,028 | 8,595 | 1,449 | 3,736 | 3,432 | 1,550 | |
Income (loss) before taxes | ||||||
-83,057 | 6,910 | -58,343 | 90,715 | 165,634 | 167,246 | |
Provision for (benefit from) income taxes | ||||||
-19,024 | 8,673 | -1,785 | 34,626 | 48,517 | -7,697 | |
Net income (loss) | ||||||
-64,033 | -1,763 | -56,558 | 56,089 | 117,117 | 174,943 | |
Less: net loss attributable to noncontrolling interest | ||||||
-1,503 | -1,474 | - | - | - | - | |
Loss from discontinued operations, net of tax | ||||||
- | - | - | - | -101 | -4,489 | |
Net income (loss) attributable to Xperi | ||||||
-62,530 | -289 | -56,558 | 56,089 | 117,016 | 170,454 | |
Income (loss) from continuing operations - Basic (in dollars per share) | ||||||
- | - | - | - | 2.26 | 3.31 | |
Income (loss) from continuing operations - Diluted (in dollars per share) | ||||||
- | - | - | - | 2.23 | 3.27 | |
Loss from discontinued operations - Basic (in dollars per share) | ||||||
- | - | - | - | - | -0.08 | |
Loss from discontinued operations - Diluted (in dollars per share) | ||||||
- | - | - | - | - | -0.08 | |
Income (loss) per share attributable to Xperi: | ||||||
Basic | ||||||
-1.27 | -0.01 | -1.15 | 1.14 | 2.26 | 3.23 | |
Diluted | ||||||
-1.27 | -0.01 | -1.15 | 1.12 | 2.23 | 3.18 | |
Cash dividends declared per share | ||||||
- | - | - | 0.80 | 0.80 | 0.92 | |
Weighted average number of shares used in per share calculations-basic | ||||||
49,120 | 48,823 | 49,251 | 49,187 | 51,802 | 52,819 | |
Weighted average number of shares used in per share calculations-diluted | ||||||
49,120 | 48,823 | 49,251 | 50,190 | 52,586 | 53,563 | |
Royalty and License Fees | ||||||
Total revenue | ||||||
280,067 | 406,133 | 373,732 | 259,565 | 273,300 | 278,807 | |